Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
In conjunction with prevention efforts, the introduction of screening examinations has resulted in a reduction of nearly 6 million cancer-related deaths since 1975.
Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.
The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.
The College of American Pathologists (CAP) has signed a five-year agreement with Cerner Corp. licensing SNOMED Clinical Terms (SNOMED CT) Core Content for unlimited global distribution.
Toshiba America Medical Systems Inc. this week introduced its new Digital Fluorography Processor 8000 (DFP-8000D) for its entire Infinix i-series systems with the new software upgrade (version V3.10) for enhanced productivity and patient care.
US Oncology Inc. is facing two class action lawsuits in the wake of its proposed merger agreement with investment partnership Welsh, Carson, Anderson & Stowe IX LP.
Positron emission tomography (PET) is gaining more evidence that the imaging modality is an accurate method of diagnosing Alzheimer's disease (AD), particularly in its early stages.
Beginning today, the Centers for Medicare & Medicaid Services (CMS) will implement several provisions of a new Medicare law that increases payment rates for rural and urban hospitals in areas with less than 1 million people.
Varian Medical Systems Inc. on Monday completed the acquisition of OpTx Corp., the Denver-based supplier of software for medical oncology practices in cancer clinics.
Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.
A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.
